Compounds that inhibit or suppress CYP2E1 activity affect AOM metabolism and hence may prevent hypermethylation and carcinogenesis of intestinal cells, and thereby early neoplastic ACF formation as well as other neoplasms [32]. The gene discussed is CYP2E1; the disease is neoplasm.